![Frank Kung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Kung
Fondateur chez
Vivo Capital LLC
Profil
Frank C.
Kung is the founder of Cetus Corp.
founded in 1981.
Dr. Kung was the founder of Genelabs Technologies, Inc. founded in 1983 and served as Chairman & Chief Executive Officer from 1983 to 1995.
Dr. Kung is the founder of Vivo Capital LLC founded in 1996 and serves as Managing Partner since 1996.
Current jobs include Chairman at Hamilton Pharmaceuticals, Inc., Director at Copernicus Therapeutics, Inc., Director at Medeor Therapeutics, Inc. since 2013, and Director at Vivo Co-Invest (S) LP.
Former jobs include Director at Pepgen Corp., Independent Director at Amyris, Inc. from 2017 to 2024, Director at Biotechnology Innovation Organization, Director at Revance Therapeutics, Inc., Director at NextWave Pharmaceuticals, Inc., Director at Sagent Holdings Co. from 2006 to 2011, Director at Nuveta, Inc., Director at West Coast Co., Ltd., Director at Asian American Manufacturers Association, Director at Monte Jade Science & Technology Association, Director at Nanjing King-friend Biochemical Pharmaceutical Co., Ltd., Non-Executive Director at BioDlink International Co., Ltd. from 2016 to 2022, and Independent Director at Sagent Pharmaceuticals, Inc. from 2011 to 2015.
Education includes an MBA degree conferred in 1983 and a doctorate conferred in 1976 from the University of California, Berkeley, and an undergraduate degree conferred in 1970 from National Tsing-Hua University.
Postes actifs de Frank Kung
| Sociétés | Poste | Début |
|---|---|---|
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Fondateur | 01/01/1996 |
Hamilton Pharmaceuticals, Inc.
 Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and supplies pharmaceuticals | Président | - |
Copernicus Therapeutics, Inc.
 Copernicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Directeur/Membre du Conseil | - |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Directeur/Membre du Conseil | 01/10/2013 |
Vivo Co-Invest (S) LP | Directeur/Membre du Conseil | - |
Anciens postes connus de Frank Kung
| Sociétés | Poste | Fin |
|---|---|---|
| AMYRIS, INC. | Directeur/Membre du Conseil | 07/05/2024 |
| BIODLINK INTERNATIONAL COMPANY LIMITED | Directeur/Membre du Conseil | 12/03/2022 |
| REVANCE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/10/2013 |
Sagent Holdings Co.
 Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur/Membre du Conseil | 20/04/2011 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Frank Kung
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Finance |
Pepgen Corp.
 Pepgen Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes products for the prevention, treatment of autoimmune and viral disorders | Health Technology |
Copernicus Therapeutics, Inc.
Copernicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Hamilton Pharmaceuticals, Inc.
Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and supplies pharmaceuticals | Commercial Services |
Amyris, Inc.
 Amyris, Inc. Chemicals: SpecialtyProcess Industries Operates as a biomanufacturing company that uses renewable biological chemistry | Process Industries |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Health Technology |
Sagent Holdings Co.
Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Nuveta, Inc.
 Nuveta, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
West Coast Co., Ltd.
 West Coast Co., Ltd. Financial ConglomeratesFinance Investment Holding Company | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Tsing-Hua University
 National Tsing-Hua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Asian American Manufacturers Association | |
Monte Jade Science & Technology Association
 Monte Jade Science & Technology Association Miscellaneous Commercial ServicesCommercial Services Operates as an organization that promotes the cooperation and mutual flow of technology and investment | Commercial Services |
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
 Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures biochemical pharmaceutical products | Health Technology |
TOT BIOPHARM International Co. Ltd.
 TOT BIOPHARM International Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets anti-tumor drugs | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Health Technology |
Vivo Co-Invest (S) LP |
